64 related articles for article (PubMed ID: 6130314)
21. Ketanserin analogues: the effect of structural modification on 5-HT2 serotonin receptor binding.
Ismaiel AM; Arruda K; Teitler M; Glennon RA
J Med Chem; 1995 Mar; 38(7):1196-202. PubMed ID: 7707322
[TBL] [Abstract][Full Text] [Related]
22. Serotonin-2 receptors coupled to phosphoinositide hydrolysis in a clonal cell line.
Ivins KJ; Molinoff PB
Mol Pharmacol; 1990 May; 37(5):622-30. PubMed ID: 2160057
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of action of ketanserin.
Millar JA; Facoory BD; Laverty R
Lancet; 1982 Nov; 2(8308):1154. PubMed ID: 6128465
[No Abstract] [Full Text] [Related]
24. The specificity of ketanserin in the inhibition of serotonin-induced steroidogenesis in the rat adrenal zona glomerulosa.
Williams BC; Shaikh S; Edwards CR
J Hypertens Suppl; 1984 Dec; 2(3):S559-61. PubMed ID: 6100754
[TBL] [Abstract][Full Text] [Related]
25. Chimeric receptor analysis of the ketanserin binding site in the human 5-Hydroxytryptamine1D receptor: importance of the second extracellular loop and fifth transmembrane domain in antagonist binding.
Wurch T; Colpaert FC; Pauwels PJ
Mol Pharmacol; 1998 Dec; 54(6):1088-96. PubMed ID: 9855638
[TBL] [Abstract][Full Text] [Related]
26. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
[TBL] [Abstract][Full Text] [Related]
27. Habituation of tactile startle is altered by drugs acting on serotonin-2 receptors.
Geyer MA; Tapson GS
Neuropsychopharmacology; 1988 May; 1(2):135-47. PubMed ID: 3150805
[TBL] [Abstract][Full Text] [Related]
28. Quipazine reduces food intake in the rat by activation of 5-HT2-receptors.
Hewson G; Leighton GE; Hill RG; Hughes J
Br J Pharmacol; 1988 Oct; 95(2):598-604. PubMed ID: 2906561
[TBL] [Abstract][Full Text] [Related]
29. Reactivity of the bronchial artery to 5-hydroxytryptamine.
Ei-Fawal HA; Ogunbiyi PO; Gordon V; Eyre P
Res Commun Chem Pathol Pharmacol; 1985 Dec; 50(3):325-36. PubMed ID: 2934778
[TBL] [Abstract][Full Text] [Related]
30. [Serotonin receptor subtypes. Considerations on their physiological role and therapeutic prospects].
Di Renzo G; Marino A
Clin Ter; 1990 Apr; 133(1):3-7. PubMed ID: 2140742
[TBL] [Abstract][Full Text] [Related]
31. Restoration of post-thrombotic peripheral collateral circulation in the cat by ketanserin, a selective 5-HT2-receptor antagonist.
Nevelsteen A; De Clerck F; Loots W; De Gryse A
Arch Int Pharmacodyn Ther; 1984 Aug; 270(2):268-79. PubMed ID: 6486973
[TBL] [Abstract][Full Text] [Related]
32. On the mechanism of action of ketanserin, a selective antagonist of the S2 receptors with antihypertensive activity.
Rión R; Mena MA; Hong E
Proc West Pharmacol Soc; 1983; 26():373-5. PubMed ID: 6889366
[No Abstract] [Full Text] [Related]
33. The effect of a selective 5-HT2 antagonist, ketanserin, on the pulmonary responses to Escherichia coli endotoxin.
Ball HA; Parratt JR; Rodger IW
Br J Pharmacol; 1983 Oct; 80(2):295-301. PubMed ID: 6360280
[TBL] [Abstract][Full Text] [Related]
34. Role of serotonin type 2 receptors in regulation of aldosterone production.
Matsuoka H; Ishii M; Goto A; Sugimoto T
Am J Physiol; 1985 Aug; 249(2 Pt 1):E234-8. PubMed ID: 2992285
[TBL] [Abstract][Full Text] [Related]
35. [3H]ketanserin labels serotonin 5-HT2 and alpha 1-adrenergic receptors in human brain cortex.
Hoyer D; Vos P; Closse A; Palacios JM; Engel G; Davies H
J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S48-50. PubMed ID: 2446070
[TBL] [Abstract][Full Text] [Related]
36. Multiple conformations of native and recombinant human 5-hydroxytryptamine(2a) receptors are labeled by agonists and discriminated by antagonists.
López-Giménez JF; Villazón M; Brea J; Loza MI; Palacios JM; Mengod G; Vilaró MT
Mol Pharmacol; 2001 Oct; 60(4):690-9. PubMed ID: 11562430
[TBL] [Abstract][Full Text] [Related]
37. 5-Hydroxytryptamine-stimulated inositol phospholipid hydrolysis in rat cerebral cortex slices: pharmacological characterization and effects of antidepressants.
Kendall DA; Nahorski SR
J Pharmacol Exp Ther; 1985 May; 233(2):473-9. PubMed ID: 2987487
[TBL] [Abstract][Full Text] [Related]
38. AT-1015, a newly synthesized 5-HT2 receptor antagonist, dissociates slowly from the 5-HT2 receptor sites in rabbit cerebral cortex membrane.
Rashid M; Watanabe M; Nakazawa M; Nagatomo T
J Pharm Pharmacol; 2002 Aug; 54(8):1123-8. PubMed ID: 12195828
[TBL] [Abstract][Full Text] [Related]
39. Effects of agonists, partial agonists, and antagonists on the regulation of 5-hydroxytryptamine2 receptors in P11 cells.
Ferry RC; Unsworth CD; Molinoff PB
Mol Pharmacol; 1993 May; 43(5):726-33. PubMed ID: 8388988
[TBL] [Abstract][Full Text] [Related]
40. [3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H] ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor.
Branchek T; Adham N; Macchi M; Kao HT; Hartig PR
Mol Pharmacol; 1990 Nov; 38(5):604-9. PubMed ID: 2233697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
